Literature DB >> 6592394

[Diagnostic significance of muscle biopsies in metabolic myopathies. I. Myopathology].

D Pongratz, G Hübner, T Deufel, I Paetzke, O H Wieland.   

Abstract

The clinical course of metabolic myopathies is dominated by progressive muscle weakness and wasting or aching contraction and recurrent rhabdomyolysis with intense exercise. Vacuolar muscle fibre degeneration is the leading pathological finding on routine histological examination. For further characterization of those histologically empty looking vacuoles, histochemistry and electron microscopy are employed. Increase of glycogen, lipid droplets or mitochondria can often be demonstrated and indicate the need for subsequent biochemical identification of the underlying metabolic defect. Some other metabolic myopathies that cause recurrent rhabdomyolysis lack myopathological abnormalities. These can only be diagnosed biochemically, but additional new histochemical screening methods might be helpful.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6592394     DOI: 10.1007/bf01721915

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Familial cirrhosis of the liver with storage of abnormal glycogen.

Authors:  D H ANDERSEN
Journal:  Lab Invest       Date:  1956 Jan-Feb       Impact factor: 5.662

3.  Myopathy due to a defect in muscle glycogen breakdown.

Authors:  B McARDLE
Journal:  Clin Sci       Date:  1951-02       Impact factor: 6.124

4.  The spectrum and diagnosis of acid maltase deficiency.

Authors:  A G Engel; M R Gomez; M E Seybold; E H Lambert
Journal:  Neurology       Date:  1973-01       Impact factor: 9.910

5.  The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.

Authors:  G Karpati; S Carpenter; A G Engel; G Watters; J Allen; S Rothman; G Klassen; O A Mamer
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

6.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

7.  Disorders of lipid metabolism in muscle.

Authors:  S Di Mauro; C Trevisan; A Hays
Journal:  Muscle Nerve       Date:  1980 Sep-Oct       Impact factor: 3.217

8.  Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency.

Authors:  S Di Donato; F Cornelio; M R Balestrini; B Bertagnolio; D Peluchetti
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

9.  Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy.

Authors:  G M Shy; N K Gonatas; M Perez
Journal:  Brain       Date:  1966-03       Impact factor: 13.501

10.  [Clinical, morphological and biochemical studies on muscle carnitine deficiency (author's transl)].

Authors:  D Pongratz; G Hübner; T Deufel; O Wieland; E Pongratz; R Liphardt
Journal:  Klin Wochenschr       Date:  1979-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.